Portfolio Manager Hedge Fund

MATTHEW J. KEEGAN

*** ***** *** ****** ********* 22B New York, NY 10282

cell: 215-***-**** email: **************@*******.*** / *******.********@*****.*** Results-generating Investment Manager who ANALYST has produced / PORTFOLIO superior performance MANAGER in up and down markets. Demonstrates a broad- based experience and a deep knowledge of the industrial and agricultural sectors. Summa Cum Laude Wharton graduate w/ a triple concentration. Investment banking and private equity foundation.

• Fundamental Research

• Equity Research; Correct Calls

• Writing Reports; Idea Generation

• Managing Analysts and Traders

• Financial Models

• Emerging Markets

• Portfolio Management • Global Markets; Critical Thinking • Financial Statement Analysis INVESTMENT EXPERIENCE

OSPRAIE MANAGEMENT, CONSULTANT 2023

• Brought in by an old employer to evaluate ~$100m private equity, pork deal; they passed relatively quickly

• Required me to understand cyclicality of the hog production industry, grain costs, executive pay, etc. FAMILY HEDGE FUND, ANALYST / PORTFOLIO MANAGER 2014-Present

• Investing in Food, Agriculture, Protein, Industrials, and Consumer sectors – opportunistic commodities; manage both a Long-only Fund and a Long/short Fund; are positioned to be profitable amidst food inflation

• Both are benchmarked against the MOO, an agribusiness ETF; in 2019, the Long-only +22%, the L/S +8.5%, the MOO +20.8%; in 2020, the Long-only +19.9%, the L/S +20%, and the MOO +13.3%; in 2021, the Long- only +58.2%, the L/S +26.5%, and the MOO +22.5%; in 2022, the Long-only +44%, the L/S +34.9%, and the MOO -10%; and in 2023, the Long-only +1.8%, the L/S +4%, and the MOO -11.3% (materials available)

• Over the last 5 yrs., a Sharpe ratio of 1.27 for the Long-only, 1.40 for the L/S, and 0.39 for the MOO; a Sortino ratio of 3.23 for the Long-only, 3.96 for the L/S, and 0.53 for the MOO

• Grew AUM by 239% in the Long-only and 131% in the L/S vs. the MOO at just 34% over the last 5 yrs.

• Funds are leveraged up to 200%, 15-30+ high-conviction positions; Long/short is limited to +/-40% net ARLON GROUP, ANALYST / PORTFOLIO MANAGER (Fund Closed in October 2013) 2008-Oct. 13

• Co-managed a long/short equity and commodity futures book for Arlon Opportunities Investors, within Continental Grain Co., a 200 yr. old private business; promoted after 1 yr. to co-mng. ~$80m w/ full discretion

• Contributed to growing AUM ~4x w/ longs outperforming the MOO by 27% (materials available)

• Total gross return of +46% vs. MOO at +36%, w/ net averaging ~80% of MOO and vol. ~20% below MOO

• Led a team of 2 analysts (5 in total) through fundamental research process; bottom-up, value based approach

• Focused on Food, Agriculture, Protein, Industrials, and Consumer sectors as well as agri-related commodities

• Long positions: an undervalued seed technology co.; short positions: a fertilizer co. overestimating its pricing OSPRAIE MANAGEMENT, EQUITIES ANALYST (Fund Closed in September 200*-****-****

• One of six equity analysts investing the long/short equity book of the $4 billion flagship Ospraie Fund, reporting directly to founder and portfolio manager Dwight Anderson; covered consumer, food, and agriculture

• Ranked among the top tier of Analysts firm-wide; profitable two-yr. track record in difficult market

• Opportunistically recommended and later added to a mortgage bond CDS position that reached $150m of notional exposure; $60m of profits resulted w/ minimal capital at risk

• Researched, analyzed, and evaluated self-directed stock ideas and made long and short recommendations

• Conducted detailed financial and operational due diligence following a bottom-up, value investing approach WELSH, CARSON, ANDERSON & STOWE, PRIVATE EQUITY ASSOCIATE 2004-2006

• Analyzed Healthcare and Information & Business Services verticals during 2-yr. program

• Sole analyst on a large minority investment into AGA Medical Corp., a maker of medical devices, in a deal that valued it at over $500m; sale to St. Jude Medical after an IPO put it a ~5x ROI in 5 yrs.

• Sole analyst for a $25m investment into MemberHealth, a Medicare Part D pharmacy benefit manager

• Extensive modeling experience: includes LBO analyses, operating and projection models, etc. GLEACHER PARTNERS, MERGERS & ACQUISITIONS ANALYST 2002-2004

• Sole analyst for Insilco Holding Co.’s $500m bankruptcy proceedings and five business unit sales

• As part of 2-yr. program, performed thorough analyses behind several M&A and restructuring initiatives EDUCATION / INTERESTS

THE UNIVERSITY OF PENNSYLVANIA, WHARTON SCHOOL 2002

• Bachelor of Science Degree in Economics w/ 3 concentrations: Finance, Management, and Legal Studies

• Graduated Summa Cum Laude, GPA: 3.98/4.00; Varsity and Freshman Crew (Lightweight; 1998 – 2002)

• Interned at Cohen Bros & Co., an equity research boutique, covering mid-sized financials: 2001 – 2002

• Interests include rowing, the Boston Red Sox, the New England Patriots, and U.S. military history; BSA Eagle Scout; Series 7 & 63 (expired); NY Cares Team Leader; Toastmasters International member

Contact this candidate